Stella Kyriakides, European Commissioner for Health and Food Safety, has given herself until the end of the year to refine her roadmap.
Its future "pharmaceutical strategy" aims to guarantee the autonomy of the European Union in the field of medicines.
These include reducing dependence on imports of active ingredients from India and China.
Read also:
When the West gave up producing its own medicines
The Covid-19 crisis has, in fact, highlighted the loss of health sovereignty in France and, more broadly, in the Old Continent.
From the start of the health crisis, concern crystallized around the risk of a shortage of anesthetics, analgesics or antibiotics in hospitals in France.
A European scourge: at the end of March, nine major hospitals in Europe launched an appeal for help, asking for international cooperation to guarantee a regular supply of medical products.
Public opinion then discovered - or realized - that two
This article is for subscribers only.
You have 70% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
Enter your email
Already subscribed?
Log in
